Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,198,658
-$480,291 QoQ
Shares Held
100,055
-50.1% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. RGNX ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in RGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,198,658 | 100,055 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,678,949 | 200,352 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,562,084 | 247,367 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,336,052 | 242,078 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,061,089 | 372,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,365,870 | 330,891 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,199,347 | 284,521 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,849,482 | 271,638 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,215,183 | 274,802 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,702,405 | 270,641 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,762,267 | 376,728 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,274,135 | 259,668 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,308,744 | 265,570 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,550,236 | 293,508 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $4,966,579 | 218,985 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,956,608 | 225,373 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,761,472 | 233,258 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,832,906 | 236,002 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,707,225 | 235,695 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,251,911 | 220,704 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,897,389 | 203,279 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,023,112 | 205,896 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,163,483 | 179,971 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,531,987 | 201,017 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,535,094 | 231,743 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,170,704 | 252,338 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||